PGY2 Ambulatory Care Pharmacy Residency Program

About The Program

Rhode Island Primary Care Physicians Corporation (RIPCPC)/ Integra’s PGY-2 Ambulatory Care Residency Program provides organized and directed pharmacy training in an outpatient primary care physician office setting.  The program centers on creating a caring and compassionate environment that promotes respect and dignity for every person.  The program develops the knowledge and skills of the residents in various areas including medication therapy management, leadership, communication, practice management, critical thinking, time management, clinical research, and teaching.  The program offers the resident the opportunity and stimulus to develop, to the highest degree obtainable, the resident’s professional expertise as a practitioner.  A RIPCPC / Integra resident is a pharmacist, first and foremost, and is expected to contribute to the achievement of the Department of Pharmacy’s mission and vision statement, as well as the annual strategic plan.  This will be achieved through participation in designated residency projects, activities, and successful completion of the program requirements. Efforts to provide optimal training and guidance for the resident will be extended whenever possible to the mutual satisfaction of the resident and the preceptor teams.  A demonstrable desire to learn, a sincere career interest in ambulatory care pharmacy practice, and a dedication to fully meeting all objectives and requirements of the residency program are expected of the resident. The program strives to train highly motivated pharmacists to develop skills in clinical service, teaching, research, and leadership.

Here is what some of the program preceptors and past residents have to say: 

RIPCPC Residency Program from Maureen Seasholtz on Vimeo.

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The program offers longitudinal experiences in ambulatory care pharmacy practice involving collaborative practice and medication therapy management in a variety of practice settings. Required learning experiences include adult primary care, geriatric care, transitions of care, and population health. Residents may choose to expand upon their primary care, geriatric care, or population health experiences through advanced elective opportunities in these areas. Additionally, residents may elect to participate in pharmacy administration or quality healthcare learning experiences that will provide opportunity to develop proficiency in innovative healthcare and pharmacy models. An academic learning experience associated with the University of Rhode Island College of Pharmacy is also available as an elective experience.  A research project is required.

Only residents that complete the minimum of twelve months of residency training equal to a full-time equivalent and fulfill the program requirements are granted a residency certificate and considered graduates of the program.

Required Learning Experiences

All experiences are longitudinal with the exception of orientation. Primary Care Employed, Primary Care Independent, Research Project, and Population Health learning experiences are 12 months in duration, while Geriatrics I and Transitions of Care are 6 months in duration (see sample schedule).

Orientation

The orientation is required and is 2 weeks in duration. During the orientation period, residency program director and preceptors will facilitate review/completion of a variety of onboarding tasks with residents. The residency program director, program coordinators, and preceptors will work with residents to create a schedule of learning experiences that will maximize potential for resident growth and development as an ambulatory care pharmacist. The RIPCPC PGY-2 Orientation Checklist will be utilized to ensure that all orientation tasks are completed.

Primary Care Employed

The RIPCPC/Integra “Primary Care Employed” learning experience is a required 50-week, longitudinal learning experience that will allow the resident to become proficient in managing common disease states seen within a primary care setting. The disease states covered include, but are not limited to, cardiometabolic syndromes, pulmonology, infectious disease, psychiatric and neurologic diseases, etc. The longitudinal structure of the learning experience is to allow the resident(s) to develop and foster working relationships with providers and prepare residents to work as an independent clinical pharmacist upon graduation from the program. This experience is scheduled for one day per week in the office, with expectations to prepare in advance.

RIPCPC/Integra is an Accountable Care Organization (ACO), which allows residents the opportunity to be exposed to both employed and independent practice models. Through the primary care employed learning experience, the resident(s) will be assigned to one day per week at an “employed” provider practice. Placement in these practices is intended to expose the resident(s) to the differences in practice management strategies. The employed practice model generally has a larger patient panel size and contains multiple providers and support staff.

The sites chosen for this learning experience will provide the resident(s) with the opportunity to work with engaged provider(s) and partake in the management of chronic conditions while directly embedded within the primary care setting. The patient panel size and patient population of the chosen practices are similar, which provides consistent experiences for both residents. Additionally, residents will be exposed to a diverse payor mix to create a well-rounded primary care learning experience.

The resident(s) will work collaboratively with the patient, the provider(s), and interdisciplinary team to develop evidence-based medication regimens and monitoring plans to improve patient outcomes. The resident(s) will receive referrals through provider and/or preceptor identification. Upon receipt of patient referrals, the resident(s) will be expected to assess medication regimens for appropriateness and provide recommendations to the referring provider while also collaborating with the interdisciplinary team, when appropriate. The resident(s) will engage in direct patient care activities, which are comprised of both in-office and/or telephonic visits. The resident(s) will complete drug information consultations and provide medication education to patients, caregivers, and providers. In addition, the resident(s) will assist with contractual obligations at practice site as directed by the primary care preceptor.

Primary Care Independent

Through the primary care independent learning experience, the resident(s) will be assigned to one day at an “independent” provider practice. Placement in these practices is intended to expose the resident(s) to the differences in practice management strategies. The independent practice model is generally limited to a single provider who has autonomy over office operations. (See Primary Care Employed for additional details regarding learning experience)

Geriatrics I

The RIPCPC/Integra “Geriatrics I” learning experience is a required, once-weekly, 24-week, longitudinal learning experience that will allow the resident to become proficient in providing medication management for the older adult population. The disease states covered include, but are not limited to, cardiovascular, renal, pulmonology, gastrointestinal, infectious disease, psychiatric and neurologic diseases, etc. The longitudinal structure of the learning experience is to allow the resident to develop and foster working relationships with providers, operate under current service models, and prepare residents to work as an independent clinical pharmacist upon graduation from the program. The site chosen for this learning experience will provide the resident with the opportunity to work with engaged provider(s) and partake in the management of chronic conditions while directly embedded within the primary care setting.

The resident(s) will develop and grow provider and patient relationships, work collaboratively with the patient and provider to develop evidence-based medication regimens and improve patient outcomes in a setting that focuses on the older adult. The resident(s) will receive referrals through provider and/or preceptor identification. Upon receipt of patient referrals, the resident(s) will be expected to assess medication regimens for appropriateness, including polypharmacy and fall reviews, and provide recommendations to the referring provider while also collaborating with the interdisciplinary team, when appropriate.

Transitions of Care

During this required 24-week, longitudinal learning experience in transitions of care, the resident will work with the clinical pharmacist specialist and medication reconciliation support specialists once weekly. The team completes transitions of care medication reconciliations in the primary care provider’s medical record on patients discharged to the home setting, including Assisted Living Facility (ALF) or Long-Term Care (LTC) facility. Notification of discharge are provided via Innovaccer, Patient 360 or The RIPCPC Report Server. Discharge summaries are found in Care Everywhere for Epic hospitals, Cerner for Care New England Hospitals, Meditech for South County Hospital or faxed and scanned into media for other hospital or skilled nursing facilities. The medication reconciliation process involves comparing the discharge summary and provider medication list and external medication history to identify changes to the medication regimens, rationale, alignment with treatment guidelines, cost-effectiveness, and access to treatments. Confirming understanding, adherence and access to medications are critical roles in this practice environment and are done primarily through telephonic outreach. Focus is also geared at avoiding preventable readmissions in high-risk populations (i.e., CHF, COPD, STEMI/NSTEMI, pneumonia and sepsis.)

To enhance the transitions of care experience, the resident may be provided with opportunities to attend home visits with the Integra nurse practitioners. This opportunity may not be offered depending on the needs of the program, anticipated time away from the learning experience or availability of the Integra providers. If interested in this opportunity, the resident should discuss with the preceptor in the first week of the rotation to collaborate if this opportunity can be made available to interested residents. The goals of the Integra programs are to limit healthcare resource utilization by reducing hospitalizations and emergency department visits. Nurse practitioner visits are offered to patients meeting criteria after returning to the home for an acute care setting and serve as a bridge to the next primary care provider (PCP) visit. During these visits, the residents will provide a thorough medication reconciliation by reviewing all medications in the home, identifying which medications to continue, when to take the medication, expectations, costs, and common side effects. Residents will work to identify and overcome barriers to adherence, problem solve with the nurse practitioner and concisely document and relay any outstanding concerns to the PCP or specialist, as appropriate.

Research Project

The resident is required to demonstrate the ability to conduct a research project. The resident will work with the guidance of the preceptor(s) to formulate a research question, conduct a literature search, determine how research will be conducted (study design, methods, data analysis), collect and interpret the data, and formally present project results. The resident will choose a project based on suggestions from the preceptors. All projects will be vetted by the preceptors for feasibility and potential impact on the team. Other preceptors may collaborate on projects, pending the selected research question. The resident will develop a research proposal including background of topic, objectives, methods, and references. The resident will present the research project and impact of results to the pharmacy department, other clinical staff, as well as to appropriate stakeholders or policy making bodies within the organization as appropriate. Pending the project scope, the resident may present the research project externally as a poster and/or platform presentation at a local, regional, or national meeting.

Population Health

The RIPCPC/Integra Population Health learning experience is a required 50 -week, longitudinal learning experience that will allow the resident to become proficient in managing patient populations within an Accountable Care Organization. The Integra ACO encompasses approximately 200 providers and 150,000 patient lives.

The resident will utilize organizational infrastructure and reporting data to target specific populations with an effort to improve patient care, meet quality metrics of value to the ACO, and sustain a viable pharmacy service.

Accountable Care Organizations (ACO) focus on improving individual health and improving the health of the entire population for which they are accountable. During this learning experience the resident(s) will work to optimize medication management for individuals by completing comprehensive medication reviews (CMRs) and to improve ACO contractual goals including adherence (renin-angiotensin system (RAS), diabetes and statin medication), statin use in diabetes, statin use in cardiovascular disease, polypharmacy, direct/indirect cost savings and assist patients with medication costs.

The resident(s) will be responsible for precepting Advanced Pharmacy Practice Experience (APPE) pharmacy students during heir dedicated population health time block. The resident(s) will learn to utilize the four preceptor roles instructing, modeling, coaching, and facilitating) when precepting the APPE students.

All experiences are longitudinal and are 6 months in duration (see sample schedule). Resident may choose two elective learning experiences.

Academia

This learning experience is designed for the PGY-2 resident to develop the requisite knowledge and skills essential in an academic environment. The resident will have the opportunity to participate in facilitating, evaluating, and mentoring student pharmacists in different activities. Assessment methodologies, creating case discussions, developing answer keys and facilitation will be emphasized. The resident will work to strengthen effective professional communication and self- assessment skills. The preceptor and other URI college faculty are open and flexible to accommodate the resident’s specific interests.

Geriatrics II

The RIPCPC/Integra “Geriatrics II” learning experience is a 24-week, elective, once weekly learning experience that will allow the resident to build and expand upon practice and service management principles in the older adult population. This learning experience is ideal for the resident with a sincere interest in geriatric patients and population health initiatives which will allow for an additional day focusing on the subject matter.

In addition to optimizing medication regimens, this experience will emphasize service management skills. The resident will strategically identify opportunities for marketing, service expansion, and/or improvements to service efficiency. The resident will become proficient at independently improving and expanding Polypharmacy/Falls/COB (concurrent opioid and benzodiazepine) services lines through coordination with preceptor(s), RIPCPC IDT members, and payors as an extension of the Geriatrics I learning experience.

The resident will continue management of various population health initiatives and healthcare conditions including, but not limited to cardiovascular, renal, pulmonology, gastrointestinal, infectious disease, psychiatric and neurologic diseases, etc., in the setting of an older adult patient population. The at-risk patient populations chosen for this learning experience will provide the resident with the opportunity to work with engaged provider(s) and partake in the management, development, and expansion of Polypharmacy/Falls/COB service lines.

The resident will further develop and grow the patient, provider, IDT, and payor relationships to develop patient-centered, evidence-based medication regimens and improve patient outcomes and quality of life. The resident will further experience assisting the older adult, and their family, as they navigate the healthcare system. The resident will demonstrate proficiency with managing medications in older adults, deprescribing, and utilizing evidence-based criteria such as The Beers Criteria, Choosing Wisely, STEADI, and STOPP/START Criteria, etc.

Primary Care II

The Primary Care II learning experience is a 24-week, elective learning experience, once weekly at a primary care practice site. Emphasis will be placed on practice management principles necessary to become a successful ambulatory care pharmacist. The experience will allow the resident to become proficient at independently managing a patient panel for 40 to 60 patients and identify opportunities to optimize practice site operations. These include managing workflows, improving service efficiency, service marketing and identifying opportunities for refining or expanding the service, and sustaining the service. The primary care site has an integrated pharmacy service with regular opportunities for workflow improvement and service enhancement. A description of the Primary Care sites is found below.

This Primary Care II Learning Experience takes place on-site at the Care New England Medical Group Family Care Center. The practice site services approximately 10,000 patients and consists of 12 attending physicians and 30 Brown University medical residents. The population largely consists of patients with Medicare and Medicaid. This primary care site also employs nurse care managers, clinical psychologist, registered dietician, and diabetes nurse educator. There is an on-site retail pharmacy. The resident is required to be on-site from 8:00 am to 4:30 pm on the designated learning experience day. In addition to emphasizing practice site and practice management operations, the resident will also manage a patient panel and be exposed to patient care areas commonly encountered in the primary care setting cardiometabolic conditions, pulmonary disorders, and polypharmacy.

Pharmacy Administration

Pharmacy Administration is an elective, once weekly, 24-week longitudinal learning experience designed to allow the resident to gain understanding of the integration of the ambulatory care pharmacist into the healthcare system from a management perspective. The RIPCPC/Integra pharmacy team is embedded in primary care practices throughout the state providing pharmacy services to approximately 150,000 patient lives with the following payor mix: Commercial (50%), Medicaid (30%), Medicare (20%).

This experience will allow the resident to develop skills required for long term practice management and sustaining ambulatory care services. The resident will work collaboratively with preceptors to identify opportunities to create or revise workflows or processes related to ambulatory care.

Quality Healthcare

The RIPCPC/Integra “Quality” learning experience is an elective, once-weekly, 24-week, longitudinal learning experience that will allow the resident to become proficient in data elements associated with quality contracts for the Accountable Care Organization (ACO). The resident will: work collaboratively with quality department staff; gain knowledge of quality contracts, payouts, quality specifications, and interdisciplinary team goals for practices assigned;  expand Primary Care learning experience knowledge to assist and improve quality scores in other RIPCPC/Integra practices; manage available quality data sets and identify improved methods for self-identification of additional at-risk patient populations to improve patient outcomes and demonstrate value to payors; strive to engage RIPCPC/Integra providers who do not currently have in-person clinical pharmacist support; provide a formal presentation to the pharmacy and interdisciplinary departments at the end of the learning experience as applicable.

Advanced Population Health

The resident is required to demonstrate the ability to conduct a population health quality improvement or research project with patients and/or providers within the RIPCPC/Integra network. This experience will be ideal for residents looking to review the impact of clinical pharmacy services, develop opportunities for clinical pharmacy services, and/or conduct small-scale pilot programs from a population health, value-based care perspective.

The resident will work with the guidance of the preceptor to formulate a question, conduct a literature search, determine how population health project will be conducted (study design, methods, data analysis), collect and interpret the data, and formally present project results. The resident will choose a project based on suggestions from the preceptors and/or resident interest. All projects will be vetted by the pharmacy team for feasibility and potential impact on the team and/or organization. The resident will develop a proposal including background of topic, objectives, methods, and references.

Resident 1

Resident 2

The RIPCPC/Integra pharmacy team is embedded in primary care practices throughout the state and provide pharmacy services to approximately 150,000 patient lives.  We strive to improve the health and wellness of our patients by practicing patient-centered, team-based, and evidence-based medicine.  We are passionate about furthering the growth of the pharmacy profession and in addition to the PGY2 Residency Program, precept University of Rhode Island APPE students.

Alex Gianfrancesco, PharmD, CDOE, CVDOE

Alex joined the team as a clinical pharmacist in July 2021, after completing her PGY2 in Ambulatory Care with RIPCPC/Integra. She graduated from MCPHS University – Boston in 2019 with her Doctor of Pharmacy degree and completed her PGY1 with the University of Rhode Island/Walgreens Community Residency Program. Upon completion of her PGY1, she also earned her Teaching Certificate through the University of Rhode Island. Alex holds state certifications in both diabetes and cardiovascular disease education. She is currently a preceptor for the “Primary Care – Independent” learning experience. Additionally, Alex was newly appointed as a Residency Program Coordinator in 2023.

Brianna Kimball, PharmD, BCACP, CDOE

Brianna is the Residency Program Director for our PGY2 Ambulatory Care Pharmacy Residency Program. Brianna joined the team as a clinical pharmacist in July of 2020 after completing her PGY2 Ambulatory Care Residency with RIPCPC/Integra. She earned her Doctor of Pharmacy degree from the University of Rhode Island College of Pharmacy and completed a PGY1 Pharmacy Residency with the VA Maine Healthcare System. Brianna is a BPS Board Certified Ambulatory Care Pharmacist (BCACP) and has her teaching certificate. She is currently a preceptor for our PGY-2 Ambulatory Care Pharmacy Residents and for URI APPE students. During Brianna’s PGY2 residency with RIPCPC, Brianna conducted a research project that involved developing and implementing a pharmacist-led chronic obstructive pulmonary disease management program at one of our outpatient primary care clinics. Brianna’s clinical pharmacy research report, “Evaluating an integrated chronic obstructive pulmonary disease management program in a primary care setting,” is published in the Journal of the American College of Clinical Pharmacy (JACCP). Brianna also assisted with the development of a collaborative hepatitis C treatment workflow in primary care.

Demetria Malone, PharmD

Demetria joined the RIPCPC/Integra team in October of 2023. She received her B.S.  in Biomedical Pharmacology from the University of Rhode Island and received her PharmD degree at the University of Saint Joseph in Hartford, CT. Demetria completed her PGY-1 Pharmacy Practice Residency at South County Health where she developed and piloted the hospital’s transitions of care (TOC) program as one of her research projects. After residency, Demetria became the lead transitions of care and inpatient diabetes clinical pharmacist at South County Health. In addition, Demetria has experience in anticoagulation management, antimicrobial stewardship and outpatient oncology management. She served as the Residency Program Coordinator at South County Health and actively precepted residents and final year pharmacy students. She holds a certification in anticoagulation management and earned her teaching certificate at URI.  Demetria is an Adjunct Clinical Assistant Professor at URI college of pharmacy.

Diana Mercurio, BSPharm, CDCES, CVDOE

Diana joined the team in December of 2016 and serves as one of the residency program coordinators as well as the Pharmacy  Department Clinical Program Development and Operations Manager.  Prior to joining  the RIPCPC/Integra team , she was employed by Prospect/Charter Care, initially in the pharmacy department and then as a member of the Performance Improvement/Quality team as the stroke coordinator and diabetes clinical manager.  She holds certificates in anticoagulation, pain management, cardiovascular disease, stroke management, and heart failure.  She is a nationally and locally certified diabetes educator.  Diana is a fellow with the Rhode Island Geriatric Education Center for certification in Interdisciplinary Practice in Geriatrics.  She is an Adjunct Clinical Assistant Professor, University of Rhode Island, College of Pharmacy and was recently appointed to the American Health Council’s Industry Board.

Jennifer Leavitt, PharmD, CDCES, CVDOE

Jen joined RIPCPC/Integra in 2016 as a clinical pharmacist and currently serves as the Manager of Clinical Pharmacy Strategies and Operations, as well as, co-coordinator of the PGY-2 residency program.  Jen graduated from the University of Rhode Island College of Pharmacy where she earned her Doctor of Pharmacy degree.  Her prior work experience includes community pharmacy, specialty pharmacy, and pharmacy benefit management.  She holds certificates in cardiovascular disease and heart failure and has earned both state and national certifications in diabetes education.

Jessica Silva, PharmD, CDOE

Jessica joined the team as a clinical pharmacist in December of 2021. She graduated from Northeastern University in 2020 with her Doctor of Pharmacy degree and completed her PGY1 Community-Based Pharmacy residency with the University of Rhode Island (URI)/Walgreens Pharmacy. During Jessica’s PGY1 residency with URI/Walgreens Pharmacy, Jessica conducted a research project on identifying barriers to vaccine uptake amid the COVID-19 pandemic. Jessica’s research, “COVID-19 and influenza vaccine hesitancy among college students,” is published in the Journal of the American Pharmacists Association. Jessica holds a state certification in diabetes education and earned her teaching certificate through URI.  She is currently a primary care preceptor for our PGY2 Ambulatory Care Pharmacy residency program.

Joseph Nardolillo, PharmD, BCACP

Joseph Nardolillo is a Clinical Assistant Professor at the University of Rhode Island College of Pharmacy and as a Clinical Pharmacist alongside the team at RIPCPC/Integra. Within this role, he practices at the Internal Medicine Clinic within the Care New England Health System in Pawtucket where he precepts pharmacy learners and facilitates clinical research. He is a graduate of the University of Rhode College of Pharmacy and completed post-graduate residencies at the Albuquerque Indian Health Center and the University of Colorado Skaggs School of College of Pharmacy and Health Sciences. He is an active member of many professional organizations including APhA, ASHP, PLS, Kappa Psi, AACP, NLA, and RxSHARE. Joe’s professional interests include ambulatory practice management, LGBTQIA+ health, and cardiovascular risk reduction in historically underserved populations. Joe serves as a preceptor for the required Research rotation and the academia and advanced population health electives.

Kaylee Mehlman, PharmD, BCGP, FASCP

Kaylee Mehlman holds a Doctor of Pharmacy (Cum Laude) from Ohio Northern University and is a Board-Certified Geriatric Pharmacist with experience in post-acute, long-term care since 2009.  Additionally, she is recognized as a Fellow of the American Society of Consultant Pharmacists (ASCP). Currently, she is a Clinical Pharmacist at Rhode Island Primary Care Physicians Corporation, Owner of Geramed Senior Care Consulting, and a Corporate Clinical Consultant for Psych360.  Nationally, she participates on the ASCP Governmental Affairs Committee and is Vice-Chair of the Antimicrobial Stewardship and Infection Control Committee. Locally, she serves as the ASCP State Delegate for the Massachusetts and Rhode Island chapters.

Maureen Conti, PharmD, BCACP, CDOE, CVDOE

Molly joined the team of clinical pharmacists in July 2021 after completion of her PGY2 Ambulatory Care Residency with RIPCPC/Integra and currently serves as a preceptor for the Primary Care learning experience. Molly is a 2019 graduate of the University of Rhode Island College of Pharmacy and completed her PGY1 residency at Pennsylvania Hospital in Philadelphia, PA. She completed a teaching certificate program during her PGY1 in affiliation with Temple University School of Pharmacy in Philadelphia and enjoys precepting both residents and URI APPE students. Molly holds a board certification in ambulatory care pharmacy, and state certifications in diabetes and cardiovascular disease education. Molly also helps to coordinate our pharmacy Instagram page (@ripcpcrx).

Ron Tutalo, PharmD, BCACP, CDCES

Ron serves as a preceptor for the Population Health and Primary Care II learning experiences. He has worked in the primary care ambulatory care setting for 8 years. His prior work experiences are in pharmacy benefit management, hospital pharmacy, and retail pharmacy. He is board certified in ambulatory care pharmacy and in diabetes care and education. He also serves as Clinical Assistant Professor at the University of Massachusetts Graduate School of Nursing and as Adjunct Clinical Assistant Professor at the University of Rhode Island College of Pharmacy.

Shannon Levesque, PharmD

Shannon joined the team as a clinical pharmacist specialist in transitions of care at the beginning of 2023 and serves as the preceptor for the required learning experience in transitions of care (TOC). Shannon previously precepted PGY-2 residents in TOC during her time at Kent Hospital. Shannon brings a lot of experience to the program having previously started a pharmacist TOC service line at Kent Hospital and enhanced the TOC program at Rhode Island Hospital. Shannon has over 20 years of clinical pharmacist experience in TOC, Ambulatory Care, Pain Management, and Hospital Pharmacy. Shannon is a dedicated member of the Rhode Island Society of Health Systems Pharmacist Board of Directors serving on the board for >15 years in many roles including President. She is an Adjunct Clinical Assistant Professor at the University of Rhode Island College of Pharmacy.

Stacey Ranucci, BSPharm, BCGP, CDCES

Stacey Ranucci serves as the Director of Pharmacy for the Rhode Island Primary Care Physicians Corporation / Integra Community Care Network.   She has 24 plus years of experience in the profession of pharmacy, is board certified in geriatric pharmacotherapy, and is a certified diabetes educator. Stacey serves as an Adjunct Clinical Associate Professor of Pharmacy Practice for the University of Rhode Island, College of Pharmacy and was appointed to the Rhode Island Department of Health’s Board of Pharmacy in 2015. She served as the board’s chairperson from 2018 through 2022.  Stacey served on the 2022 NABP Resolutions Committee for District 1 and was the NABP District 1 Chairperson. Stacey was elected to NABP Executive Committee at the May 2023 NABP Annual Meeting and currently serves as the district 1 representative. Stacey graduated from the University of Rhode Island in 1998 and is currently enrolled in the Executive MBA program at Nichols College in Dudley, Massachusetts.

• Stipend: $49,000 per 12 months
• Medical, dental, and vision insurance
• 11 paid holidays: New Year’s Day, Martin Luther King Jr. Day, President’s Day, Memorial Day, Juneteenth, Independence Day, Labor Day, Columbus Day, Thanksgiving, Day after Thanksgiving, Christmas Day
• 80 hours of paid time off (PTO): 40 hours between July – December and 40 hours between January – June
• Company issued laptop and cell phone
• Mileage reimbursement for work travel-related expenses
• Travel, hotel, and conference allowance
• Continuing education allowance

Submit your application materials via Pharmacy Online Residency Centralized Application Service (PhORCAS) by application deadline to be considered for the RIPCPC/Integra PGY2 Ambulatory Care Residency Program. Please refer to application deadline in PhORCAS.

Candidate Requirements

Applicants must meet the following qualifications to be considered for the program:

• Graduate of an ACPE-accredited School of Pharmacy.
• Applicants must be participating in or have completed an ASHP-accredited or candidate for accreditation PGY1 Pharmacy Residency Program
• Eligible for pharmacist licensure in Rhode Island.
• Flexibility to start on a pre-determined date. Ask the program director for the exact date. Adjustments to the start date are not allowed.

The Pharmacy Residency programs participate in the Residency Matching Program (“The Match”). After “The Match”, employment as a pharmacy resident is still contingent upon the applicant satisfying RIPCPC’s employment eligibility requirements.

Application Process

Please apply through the Pharmacy Online Residency Centralized Application Service (PhORCAS).

Your application must include:

• Letter of interest, specifying:
  • Your personal career goals
• Why you’re interested in residency training, what you’re looking for in a residency program and why you’re interested in our program
• Curriculum vitae (CV)
• Three references (separate letter not required)
• Pharmacy school transcripts

Virtual Interview

All Pharmacy Residency Candidates must complete a virtual interview. A request to reschedule an interview date will only be granted in extenuating circumstances.

Audrey Whalen, PharmD

• Completed PGY1 Community-Based Pharmacy Residency at URI/Walgreens

Laura Lerner, PharmD

• Completed PGY1 Community-Based Pharmacy Residency at Penobscot Community Health Center in Bangor, ME

Class of 2022-2023

Anna Mortali, PharmD

·         Clinical Pharmacist Specialist in Ambulatory Care (Primary Care), Baystate Health

Gisela Canales, PharmD

• Collaborative Drug Therapy Management (CDTM) Pharmacist, NYC Health + Hospitals

Class of 2021-2022

Chelsey Quinlan, PharmD

• Clinical Pharmacist Specialist in Ambulatory Care (Dermatology), Yale New Haven Health

Class of 2020-2021

Alex Gianfrancesco, PharmD, CDOE, CVDOE

• Clinical Pharmacist Specialist in Ambulatory Care, RI Primary Care Physicians Corporation

Maureen Conti, PharmD, BCACP, CDOE, CVDOE

• Clinical Pharmacist Specialist in Ambulatory Care, RI Primary Care Physicians Corporation

Class of 2019-2020

Brianna Kimball, PharmD, BCACP, CDOE

• Clinical Pharmacist Specialist in Ambulatory Care, RI Primary Care Physicians Corporation

Maria Charbonneau, PharmD

• Clinical Assistant Professor of Pharmacy Practice at Western New England College of Pharmacy and Health Sciences

Pharmacy Team Publications List